Venker Eric's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Jan 4, 2023
- Accession no.
- 0001140361-23-000545
- Filed
- Jan 4, 2023
- Trade date
- Dec 30, 2022-Jan 3, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $889.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Venker EricCIK 0001801917 | Officer (President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2022 | Common Shares | SSaleDisposed | −23,761 | $8.00 | −$190,088 | 848,950 | Direct | |
| Jan 3, 2023 | Common Shares | SSaleDisposed | −95,484 | $7.32 | −$698,942.88 | 753,466 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.